Thymosin Alpha-1 vs Thymosin Beta 4 for pain & inflammation
Short answer: For pain & inflammation, users rate them about the same: 100% report improvement with Thymosin Alpha-1 (3 reports) and 100% with Thymosin Beta 4 (2 reports).
Thymosin Alpha-1 has 11 meta-analyses and 35 randomized trials on PubMed; the other has not been graded.
Based on 51 reports about Thymosin Alpha-1 and 23 about Thymosin Beta 4. Not medical advice.
| Thymosin Alpha-1 Peptide | Thymosin Beta 4 Peptide | |
|---|---|---|
| User score | 35 | 26 |
| Verdict | Mostly positive | Mixed |
| Positive of reports that state an outcome | 77% | 56% |
| Reports | 51 | 23 |
| Research | AResearch: Strong | Research pending |
| Meta-analyses / RCTs | 11 / 35 | — |
| Mainly used for | ||
| Recovery % reporting improvement | — | 88% (8) |
| Pain & inflammation % reporting improvement | 100% (3) | 100% (2) |
| Skin & hair % reporting improvement | — | 100% (2) |
| Immunity % reporting improvement | 100% (13) | — |
| Common side effects | rapid hr, throat swelling, sneezing, flushing | inflammation |
| Typical dose reported | Not listed | Not listed |
Based on the results of the included studies, there is insufficient evidence to support or refute the effectiveness of different interventions for avulsed and replanted permanent front teeth. The overall quality of existing evidence was very low, and therefore great caution should be exercised when generalising the results of the included trials. There is urgent need for further well-designed randomised controlled trials.
Cochrane Database Syst Rev, 2019 ↗“Get on injectable peptides (BPC-157, TB-500, Thymosin Alpha-1).”
“Thymosin Beta 4 and BPC-157 combined cannot be beat when it comes to recovery, hands down, there is no better alternative I have ever seen in my life.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate